Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptide

CDKN3 Reactivité: Mammifères Hôte: Synthetic BP, WB, IHC
N° du produit ABIN937106

Aperçu rapide pour Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptide (ABIN937106)

Antigène

CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))

Origine

Mammifères

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Type de proteíne

    Synthetic

    Séquence

    CKFKDVRRNV QKDTEELKSC GIQDIFVFCT RGELSKYRVP NLLDLYQQCG

    Attributs du produit

    A synthetic peptide for use as a blocking control in assays to test for specificity of CDKN3 antibody,
    Alternative Names: CDKN3 control peptide, CDKN3 antibody Blocking Peptide, Anti-CDKN3 Blocking Peptide, Cyclin-Dependent Kinase Inhibitor 3 Blocking Peptide, Cdk2-Associated Dual Specificity Phosphatase Blocking Peptide, CDI1 Blocking Peptide, CIP2 Blocking Peptide, FLJ25787 Blocking Peptide, KAP Blocking Peptide, KAP1 Blocking Peptide, MGC70625 Blocking Peptide
  • Indications d'application

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20 °C long term.
  • Antigène

    CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))

    Sujet

    The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers.

    Poids moléculaire

    23 kDa
Vous êtes ici:
Chat with us!